SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-033143
Filing Date
2023-09-20
Accepted
2023-09-20 09:00:16
Documents
12
Period of Report
2023-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44250
  Complete submission text file 0001493152-23-033143.txt   216414

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20230914.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ocx-20230914_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocx-20230914_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3185
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 231265401
SIC: 2835 In Vitro & In Vivo Diagnostic Substances